David S Wichmann's most recent trade in Privia Health Group Inc was a trade of 8,396 Common Stock, par value $0.01 per share done . Disclosure was reported to the exchange on May 21, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Privia Health Group Inc | David S. Wichmann | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2025 | 8,396 | 25,709 | - | 0 | Common Stock, par value $0.01 per share | |
| Boston Scientific | David S. Wichmann | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 May 2025 | 2,081 | 41,582 (0%) | 0% | 0 | Common Stock | |
| Privia Health Group Inc | David S. Wichmann | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2024 | 11,124 | 17,313 | - | 0 | Common Stock, par value $0.01 per share | |
| Boston Scientific | David S. Wichmann | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 May 2024 | 2,901 | 39,501 (0%) | 0% | 0 | Common Stock | |
| Privia Health Group Inc | David S. Wichmann | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Aug 2023 | 6,189 | 6,189 | - | 0 | Common Stock, par value $0.01 per share | |
| Boston Scientific | David S. Wichmann | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 May 2023 | 3,946 | 36,600 (0%) | 0% | 0 | Common Stock | |
| Boston Scientific | David S. Wichmann | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Apr 2023 | 41 | 32,654 (0%) | 0% | 0 | Common Stock | |
| Boston Scientific | David S. Wichmann | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2022 | 4,877 | 29,877 (0%) | 0% | 0 | Common Stock | |
| Boston Scientific | David S. Wichmann | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2022 | 2,736 | 32,613 (0%) | 0% | 0 | Common Stock | |
| Boston Scientific | David S. Wichmann | Director | Purchase of securities on an exchange or from another person at price $ 41.98 per share. | 15 Nov 2021 | 25,000 | 25,000 (0%) | 0% | 42.0 | 1,049,450 | Common Stock |
| Boston Scientific | David S. Wichmann | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2021 | 4,093 | 4,093 | - | - | Deferred Stock Units | |
| Boston Scientific | David S. Wichmann | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2021 | 2,296 | 6,389 | - | - | Deferred Stock Units | |
| UnitedHealth | David S. Wichmann | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 339.58 per share. | 15 Dec 2020 | 465 | 967,872 (0%) | 0% | 339.6 | 157,907 | Common Stock |
| UnitedHealth | David S. Wichmann | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Dec 2020 | 113 | 968,337 (0%) | 0% | 0 | Common Stock | |
| Tennant Co. | David S. Wichmann | Director | Sale of securities on an exchange or to another person at price $ 67.63 per share. | 03 Dec 2020 | 1,750 | 14,722 (0%) | 0% | 67.6 | 118,356 | Common Stock |
| Tennant Co. | David S. Wichmann | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Dec 2020 | 1,750 | 0 | - | - | Stock Option (right to buy) | |
| Tennant Co. | David S. Wichmann | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 40.81 per share. | 03 Dec 2020 | 1,750 | 16,472 (0%) | 0% | 40.8 | 71,418 | Common Stock |
| UnitedHealth | David S. Wichmann | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Sep 2020 | 130 | 968,224 (0%) | 0% | 0 | Common Stock | |
| UnitedHealth | David S. Wichmann | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 323.70 per share. | 14 Aug 2020 | 597 | 968,093 (0%) | 0% | 323.7 | 193,249 | Common Stock |